News . Data . Research
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company that works with research universities and medical centers to develop and commercialize their discoveries,
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biotechnology company that operates by partnering with leading researchers to accelerate new discoveries in the healthcare
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates
Medical device maker CooperCompanies (NYSE: COO) announced financial results for the third quarter of 2023, reporting an increase in revenues. Third-quarter revenue
Ocean Biomedical, Inc. (NASDAQ: OCEA), a leading biopharma company that works to accelerate the development and commercialization of scientifically compelling assets from
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decrease in revenues for the second quarter of fiscal
Key highlights from Cardinal Health Inc (CAH) Q4 2023 Earnings Concall Management Update: [00:02:00] CAH delivered record financial performance, including its highest
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company that operates by partnering with leading researchers to accelerate new discoveries in the
Pharmaceuticals distributor Cardinal Health (NYSE: CAH) announced financial results for the fourth quarter of 2023, reporting higher revenues and adjusted profit. Revenues
Key highlights from Illumina, Inc (ILMN) Q2 2023 Earnings Concall Management Update: [00:07:42] ILMN now expects to ship more than 390 NovaSeq
Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday provided an update on its broad range of programs in malaria, fibrosis, and multiple cancers.
Biotechnology company Illumina, Inc. (NASDAQ: ILMN) on Wednesday announced financial results for the second quarter of 2023. Second-quarter revenue came in at
Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and earnings for the second quarter of 2023. Second-quarter revenue came
Key highlights from Charles River Laboratories International, Inc (CRL) Q2 2023 Earnings Concall Q&A Highlights: [00:34:34] Sandy Draper with Guggenheim asked if
Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the second quarter of 2023. For the
Trxade Health Inc. (NASDAQ: MEDS) is a healthcare IT company that constantly innovates and expands into new verticals, with the latest such
Ocean Biomedical, Inc. (NASDAQ: OCEA) on Wednesday shared collective analyst research coverage from three firms, with current Buy recommendations and share price
Key highlights from Eli Lilly and Company (LLY) Q2 2023 Earnings Concall Q&A Highlights: [00:36:01] Louise Chen from Kantor asked about the
Biotechnology company Bio-Techne Corporation (NASDAQ: TECH) on Tuesday announced financial results for the fourth quarter of 2023, reporting an increase in profit.
Eli Lilly and Company (NYSE: LLY) reported second quarter 2023 earnings results today. Revenue increased 28% to $8.3 billion compared to the
Amgen Inc. (NASDAQ: AMGN) on Friday reported higher revenues and adjusted earnings for the second quarter of 2023. The biotechnology firm also